Page last updated: 2024-08-25

cholest-5-ene-3,4-diol and levetiracetam

cholest-5-ene-3,4-diol has been researched along with levetiracetam in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Haslemo, T; Hole, K; Molden, E; Nguyen, C; Wollmann, BM	1

Other Studies

1 other study(ies) available for cholest-5-ene-3,4-diol and levetiracetam

Article	Year
Comparison of CYP3A4-Inducing Capacity of Enzyme-Inducing Antiepileptic Drugs Using 4β-Hydroxycholesterol as Biomarker. Therapeutic drug monitoring, 2018, Volume: 40, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Biomarkers; Carbamazepine; Cytochrome P-450 CYP3A Inducers; Drug Monitoring; Enzyme Induction; Female; Humans; Hydroxycholesterols; Levetiracetam; Male; Middle Aged; Phenobarbital; Phenytoin; Retrospective Studies; Young Adult	2018

Article

Year

Comparison of CYP3A4-Inducing Capacity of Enzyme-Inducing Antiepileptic Drugs Using 4β-Hydroxycholesterol as Biomarker.

Therapeutic drug monitoring, 2018, Volume: 40, Issue:4

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Biomarkers; Carbamazepine; Cytochrome P-450 CYP3A Inducers; Drug Monitoring; Enzyme Induction; Female; Humans; Hydroxycholesterols; Levetiracetam; Male; Middle Aged; Phenobarbital; Phenytoin; Retrospective Studies; Young Adult

2018